NPI: 1841611530 · MONROE, NC 28110 · Internal Medicine Physician · NPI assigned 12/23/2013
Authorized official RISSMILLER, SCOTT controls 20+ related entities in our dataset. Read more
| Authorized Official | RISSMILLER, SCOTT (ENTERPRISE EVP) |
| Parent Organization | CAROLINAS PHYSICIANS NETWORK INC |
| NPI Enumeration Date | 12/23/2013 |
Other providers sharing the same authorized official: RISSMILLER, SCOTT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,884 | $510K |
| 2019 | 11,068 | $576K |
| 2020 | 7,644 | $430K |
| 2021 | 19,417 | $876K |
| 2022 | 23,314 | $1.16M |
| 2023 | 21,650 | $919K |
| 2024 | 15,207 | $601K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22,465 | 19,575 | $1.84M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26,665 | 21,278 | $1.47M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14,298 | 10,254 | $617K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8,068 | 6,519 | $473K |
| 99051 | 14,041 | 12,500 | $325K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 9,940 | 8,620 | $129K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,545 | 1,101 | $112K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 620 | 551 | $78K |
| 99215 | Prolong outpt/office vis | 147 | 142 | $15K |
| 71046 | Radiologic examination, chest; 2 views | 327 | 314 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 259 | 178 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 14 | 14 | $908.18 |
| 87807 | 72 | 44 | $813.05 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16 | 13 | $644.96 |
| 81003 | 119 | 113 | $300.41 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12 | 12 | $113.15 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 28 | 17 | $3.95 |
| 1159F | 6,492 | 5,726 | $0.15 | |
| 3074F | 156 | 154 | $0.00 | |
| 2010F | 15 | 15 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 117 | 71 | $0.00 |
| 1160F | 3,633 | 3,399 | $0.00 | |
| 3078F | 135 | 133 | $0.00 |